Evidence map›Paper›PMID 37448654›Full record

ArticleFrontiers in public health2023

Increasing incidence of

Xiaoxiao Wang, Wenjie Xu, Fei Luo, Kangming Lin, Tao Zhang, Linong Yao, Xuan Zhang, Jiaqi Zhang, Sarah Auburn, Duoquan Wang and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xiaoxiao WangDepartment of Infectious Diseases, Zhejiang Center of Disease Control and Prevention, Hangzhou, China.
Wenjie XuDepartment of Infectious Diseases, Zhejiang Center of Disease Control and Prevention, Hangzhou, China.
Fei LuoDepartment of Endemic and Parasitic Diseases, Chongqing Center for Disease Control and Prevention, Chongqing, China.
Kangming LinDepartment of Infectious Diseases, Guangxi Center of Disease Control and Prevention, Nanning, China.
Tao ZhangDepartment of Infectious Diseases, Anhui Center of Disease Control and Prevention, Hefei, China.
Linong YaoDepartment of Infectious Diseases, Zhejiang Center of Disease Control and Prevention, Hangzhou, China.
Xuan ZhangDepartment of Infectious Diseases, Zhejiang Center of Disease Control and Prevention, Hangzhou, China.
Jiaqi ZhangDepartment of Infectious Diseases, Zhejiang Center of Disease Control and Prevention, Hangzhou, China.
Sarah AuburnGlobal and Tropical Health Division, Menzies School of Health Research and Charles Darwin University, Darwin, NT, Australia.
Duoquan WangNational Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention, Shanghai, China.
Wei RuanDepartment of Infectious Diseases, Zhejiang Center of Disease Control and Prevention, Hangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: This study aimed at exploring the epidemiological pattern of imported malaria in China before malaria elimination in 2021, to provide evidence-based data for preventing malaria re-establishment in China. Methods: Nine-year surveillance data on imported malaria in four provincial-level administrative divisions (PLADs) (Anhui, Chongqing, Guangxi, and Zhejiang) between 2011 and 2019 were thoroughly collected and analyzed. Results: A quite stable trend in imported malaria cases between 2011 and 2019 was observed. In total, 6,064 imported patients were included. Conclusion: Imported malaria still poses a threat to the malaria-free status of China. County-level institutions are the primary targets in China to improve the sensitivity of the surveillance system and prevent the re-establishment of malaria. Health education should focus on exported labors, especially to Western and Central Africa. Increasing trend in

Indexed as

MalariaPlasmodium ovaleAdultChinaHumansIncidenceMiddle AgedPlasmodium vivaxYoung AdultChinaimported malariamedical visit patternmigrant workerssurveillanceWestern Africa

Identifiers

PMID37448654
PMCPMC10338171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.